Business
Apellis Pharmaceuticals, a Biotech Firm Focused on Rare Diseases and Ophthalmology, is ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Apellis Pharmaceuticals, a biotech firm focused on rare diseases and ophthalmology, is drawing takeover interest from larger drugmakers ...'
Apellis Pharmaceuticals, a biotech firm focused on rare diseases and ophthalmology, is drawing takeover interest from larger drugmakers https://t.co/CSEMvV4Vcj— Bloomberg (@business) April 3, 2023
(The above story first appeared on LatestLY on Apr 03, 2023 07:11 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
